Company intelligence / Profile preview

HH Consultancy

Ownership: Private
Development stage: Other

Overview

HH Consultancy is a specialist consulting firm focused on supporting the development and regulatory approval of biologics and biopharmaceuticals at any stage, from preclinical through to commercial launch. The firm offers expertise in process design, troubleshooting, regulatory submissions, formulation development for sterile parenterals, stability programs, QC testing panel design, and mitigation of regulatory sanctions such as FDA warning letters or consent decrees[1]. They have experience negotiating with health authorities as subject matter experts.

Modalities: BiologicSmall molecule
Industry: Consulting

Beyond the preview

Go deeper on HH Consultancy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HH Consultancy.

Explore the full profile